Heramed Ltd · ASX:HMD
Heramed — Investor Presentation (December 2024)
27 slides from Heramed's investor presentation, Dec 4, 2024
Slide 1: Leading the Digital Transformation of Maternity Care
Leading the Digital Transformation of Maternity Care Investor Presentation | December 2024
Slide 2: Disclaimer
Disclaimer This presentation has been prepared by HeraMED Limited ('HMD'). All information contained in this presentation (including this notice) ('Information') is confidential. By receiving the Information you are deemed to agree that you will hold the Information in strict confidence, and keep it
Slide 3: Problem
Problem Century-old Model of care Maternal mortality Access/inequity of care Affordability of care Workforce shortage & burnout 3
Slide 4: Our Mission
Our Mission Redefining How Maternity Care Experienced (Mums) Is Delivered and Experienced Delivered (Physicians) 4
Slide 5: Investment Highlights
Investment Highlights Maternity care in Crisis Globally Market Leading Platform Strong Evidence Base Significant global market Medical grade, clinically HeraCARE has demonstrated; opportunities ahead through validated, end-to-end ✔ Improved Care Outcomes maternity related challenges digital remote m
Slide 6: Overview
Overview HeraMED Limited is an ASX listed (ASX:HMD) global medical data and technology company leading the digital transformation of maternity care. $18.1m 0.903m Market capitalisation1 Average daily volume HeraMED offers a proprietary platform that utilises hardware and software to reshape the Doct
Slide 7: Key Leadership Team
Key Leadership Team Anoushka Gungadin Nicole Zappala Managing Director & CEO Head of Customer Success & Head Mom A career spans more than 20 years and four Over 15 years of experience in startups, including a continents, an experienced CEO, Finance decade in health tech. Passionate about reimagining
Slide 8: Maternity Care Model Challenges
Maternity Care Model Challenges An unchanged care model since 1950's Challenges for Challenges for C Expectant Mothers Doctors and Providers Dramatic shortage of staff and fundamental services Lack of time and attention Episodic, reactive, not connected patient engagement Pregnancy complications and
Slide 9: Worsening Access to Care in US
Worsening Access to Care in US Maternity deserts in the US are defined by counties with NO maternity clinic within the Country By the Numbers………. • $111bn spent on maternity care annually • Mortality rates are 2x that of other OECD countries • More than 400 hospitals closed their maternity units bet
Slide 10: Cost of maternity complications
Cost of maternity complications* Opportunity to reduce costs & improve maternity care and outcomes Maternal Mental Health Hypertension Gestational US$18.1b annual cost Diabetes related to mental health US$7.5B annual cost conditions (suicide, US$4.8b annual cost related to hypertensive overdose/subs
Slide 11: HeraCARE Solution
HeraBEAT FHR HeraCARE Solution A New Era of Connected Maternity Care Health Care Provider Blood Pressure Weight Companion App Mood RPM Remote Pregnancy Smart Messaging Monitoring Surveys Connected Devices HeraCARE Cloud Personalised Care Plans Glucose Education Expectant Mother Telehealth Care Manag
Slide 12: HeraCARE: New Era of Connected Maternity Care
HeraCARE: New Era of Connected Maternity Care Task based care plans following clinical pathways Low Risk High Risk HDP GDM Fetal Surveillance Hypertensive disorders of pregnancy Gestational Diabetes Weekly Measurements Twice Daily Measurements Twice Daily Measurements Daily Measurement Tasks Prenata
Slide 13: HeraCARE Stakeholder Benefits
BETTER HEALTH OUTCOMES ● Patient-centric care ● Continuous support from care team HeraCARE ● Empowerment ● Stress & anxiety reduction Stakeholder ● ● Education Early detection of complications eg preeclampsia Benefits INCREASED PRODUCTIVITY GAINS Productivity gains of 33%-46% for healthcare provider
Slide 14: A Wealth of Maternity Care Data Points
A Wealth of Maternity Care Data Points Key Strategic Partners in place Customised Care plans 10 customers across US, Aust & 9 care plans now established EU including hospitals, clinics, with customers including; digital healthcare platforms and research institutions Low risk, high risk, GDM, mental
Slide 15: HeraCARE Platform Momentum
HeraCARE Platform Momentum Accumulated Mums on HeraMED Platform Further Opportunities >3,955 ✔ Early >3255 Clinical Intervention ✔ Accelerate ‘Data As An Asset’ Approach ✔ Use and Integration of Proprietary AI Tools and Analysis Accumulated Mums Archived Mums 15
Slide 16: Four-Point Strategic Plan
Four-Point Strategic Plan Non-Dilutive Sustainable Commercialisation Strategic Brand 2 3 Funding / 4 Long-Term Growth 1 Focus – Customer Partnerships Grants Visibility First Focusing on near term Continuing to work Develop a Set-up a women’s ✔ Cash Flow commercial contracts with industry and strateg
Slide 17: Our stakeholders
Our stakeholders Government Key verticals, markets & strategic partnerships Commercial Health Insurers/ Partners Employers Hospitals and Clinics Care Management Service Providers Midwife-led Research Institutes Maternity Groups & Universities 17
Slide 18: Pregnant mothers endorsing HeraCARE
HERA @ Pregnant mothers endorsing HeraCARE i 87% KKKK I a . Satsaction Ging - 39% ..¢ Contributed to yy » Peace of Mind a 7 86% Preferred the RPM Experience -HERA 8 _MED @
Slide 19: Key Customer – Broward Health
Key Customer – Broward Health Broward – a top-10 USA Public Health Provider • 5 Hospitals, 50 health centres, 11,000+ staff • 5,800 annual pregnancies Commercial Agreement Terms • 2-year agreement for HeraCARE platform and HeraBEAT devices in Broward health service • 700 HeraCARE licences & 200 hard
Slide 20: Key Channel Partner - Lovu
Key Channel Partner - Lovu Strategic Partnership Update: Lovu Health • US-based digital ecosphere & marketplace for technology and services companies HeraMED & Lovu • Channel partner into private clinic markets in California, Texas, Ohio • HeraCARE forms backbone of Lovu Health’s care ecosystem Noel
Slide 21: On the Path to Adoption in Australia
On the Path to Adoption in Australia GC University Hospital, Telstra Health and UTS – Direct, Channel Partner, Research Gold Coast Telstra University University Hospital Health Technology Sydney Clinical Trial Launched Telstra Health Soft at GC Hospital2 5 year Strategic Partnership1 Launch of HeraC
Slide 22: HeraCARE Commercial Model
HeraCARE Commercial Model Pricing Model Example Reimbursement In The US Allows Healthcare Providers To Receive Additional Revenue Per Pregnancy Reimbursement Per Pregnancy Private clinic Per Pregnancy ~US$600 99453 ~$19 One Time $19 99454 ~$62 Avg. 5-month usage $310 OR 99457 ~$52 Avg. 5-month usage
Slide 23: Future of Maternity Care - Pregnancy + AI
Future of Maternity Care - Pregnancy + AI Admin, Demographics • Predictive Risk mapping • Identification of high risk Vital Signs (Weight, MHR, BP) complications • Advanced personalised FHR care plans Descriptive Predictive Psychosocial data Analytics Analytics • Improved pregnancy monitoring Patien
Slide 24: ESG Leadership
ESG Leadership Leveraged To Participate In Long-Term Structural ESG Trends HeraMED - Key ESG Initiatives and Achievements #1 Ukraine Supporting mothers at war using remote patient monitoring #2 Rozana Building bridges between Israeli & Palestinian through health #3 Ethiopia & Nepal Reducing maternal
Slide 25: Recent Achievements and Upcoming Milestones
Recent Achievements and Upcoming Milestones May Oct Nov Jun Jul Aug Sep Dec 24, Jan, Feb, March 25 USA - Broward Health, Scale & rollout multiple care plans; Further commercial agreements 9 April 10 May 17 June 15 July 25 Aug 23 Sep 8 Oct 11 Nov executed Change Strategic HeraCARE UTS Strategic Grant
Slide 26: HeraMED Limited (ASX:HMD)
HeraMED Limited (ASX:HMD) Anoushka Gungadin Managing Director & CEO E: anoushka@hera-med.com M:+61 431 131 649 Tim Chapman Chairman E: tchapmanm@claritycap.com.au M: +61 419 897 062 26
Slide 27: Board of Directors, Leadership team, Advisory Board
Board of Directors Tim Chapman Anoushka Gungadin David Hinton Chairman Managing Director Non-Executive Director Leadership team Anoushka Gungadin Cameron Jones Nicole Zappala Dr. Arturo Weschler Moran Shochat Ariel Laden Chief Executive Officer Chief Financial Officer Head Mom /Customer Success Chie